FDA revises labeling to limit pediatric use of prescription cough and cold medicines

E-ISSN： 1556-7567|20|2|8-8

ISSN： 1527-8395

Source： THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol.20, Iss.2, 2018-02, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FDA issues warning about off‐label pediatric use of tramadol

THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol. 17, Iss. 11, 2015-11 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

Over-the-counter cough and cold medicines for children: A comparison of UK and US parents' parental usage, perception and trust in governmental health organisation

By Himmelstein M. Miron-Shatz T. Hanoch Y. Gummerum M.

Health, Risk & Society, Vol. 13, Iss. 5, 2011-08 ,pp. : 451-468

Routledge Ltd

Access to resources Recommend Favorite

FDA approves labeling update for extended‐release aripiprazole

THE BROWN UNIVERSITY PSYCHOPHARMACOLOGY UPDATE, Vol. 26, Iss. 2, 2015-02 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs

NURSING FOR WOMENS HEALTH, Vol. 19, Iss. 3, 2015-06 ,pp. : 266-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Over-the-counter cough medicines in children: neither safe or efficacious?

By Smith Susan M Henman Martin Schroeder Knut Fahey Tom

British Journal of General Practice, Vol. 58, Iss. 556, 2008-11 ,pp. : 757-758

Royal College of General Practitioners

Access to resources Recommend Favorite